flumazenil has been researched along with Limb-Girdle Muscular Dystrophies in 6 studies
Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Justel, M | 1 |
| Jou, C | 1 |
| Sariego-Jamardo, A | 1 |
| Juliá-Palacios, NA | 1 |
| Ortez, C | 1 |
| Poch, ML | 1 |
| Hedrera-Fernandez, A | 1 |
| Gomez-Martin, H | 1 |
| Codina, A | 1 |
| Dominguez-Carral, J | 1 |
| Muxart, J | 1 |
| Hernández-Laín, A | 1 |
| Vila-Bedmar, S | 1 |
| Zulaica, M | 1 |
| Cancho-Candela, R | 1 |
| Castro, MDC | 1 |
| de la Osa-Langreo, A | 1 |
| Peña-Valenceja, A | 1 |
| Marcos-Vadillo, E | 1 |
| Prieto-Matos, P | 1 |
| Pascual-Pascual, SI | 1 |
| López de Munain, A | 1 |
| Camacho, A | 1 |
| Estevez-Arias, B | 1 |
| Musokhranova, U | 1 |
| Olivella, M | 1 |
| Oyarzábal, A | 1 |
| Jimenez-Mallebrera, C | 1 |
| Domínguez-González, C | 1 |
| Nascimento, A | 1 |
| García-Cazorla, À | 1 |
| Natera-de Benito, D | 1 |
| Mavillard, F | 1 |
| Madruga-Garrido, M | 1 |
| Rivas, E | 1 |
| Servián-Morilla, E | 1 |
| Ávila-Polo, R | 1 |
| Marcos, I | 1 |
| Morón, FJ | 1 |
| Paradas, C | 1 |
| Cabrera-Serrano, M | 1 |
| Herczegfalvi, A | 1 |
| Pikó, H | 1 |
| Karcagi, V | 1 |
| Aranka, L | 1 |
| Peter, M | 1 |
| Jeno, K | 1 |
| Katalin, R | 1 |
| Gyula, T | 1 |
| Emoke, E | 1 |
| Agnes, H | 1 |
| Tibor, H | 1 |
| Laszlo, T | 1 |
| Edit, B | 1 |
| Marta, K | 1 |
| Janos, S | 1 |
| Veronika, K | 1 |
| Spengos, K | 1 |
| Walter, MC | 1 |
| Dekomien, G | 1 |
| Papadopoulos, K | 1 |
| Lochmüller, H | 1 |
| Manta, P | 1 |
| Georgieva, B | 1 |
| Todorova, A | 1 |
| Tournev, I | 1 |
| Mitev, V | 1 |
| Kremensky, I | 1 |
6 other studies available for flumazenil and Limb-Girdle Muscular Dystrophies
| Article | Year |
|---|---|
Expanding the phenotypic spectrum of
Topics: Humans; Intellectual Disability; Microcephaly; Muscle Weakness; Muscular Dystrophies; Muscular Dystr | 2023 |
NOVEL intronic CAPN3 Roma mutation alters splicing causing RNA mediated decay.
Topics: Adolescent; Calpain; Child; Female; Founder Effect; Humans; Introns; Male; Muscle Proteins; Muscular | 2019 |
[Screening for hereditary neuromuscular disorders with molecular genetic methods in the Roma population of Hungary].
Topics: Cataract; Face; Founder Effect; Frameshift Mutation; Gene Deletion; Hereditary Sensory and Motor Neu | 2008 |
Genetically determined neuromuscular disorders of some Roma families living in Hungary.
Topics: Abortion, Therapeutic; Adolescent; Adult; Age of Onset; Aged; Child; Electromyography; Female; Gene | 2009 |
C283Y mutation in the gamma-sarcoglycan gene in Greek Gypsies with severe limb girdle muscular dystrophy.
Topics: Child; Child, Preschool; Female; Founder Effect; Greece; Humans; Infant; Male; Muscular Dystrophies, | 2010 |
C283Y gamma-sarcoglycan gene mutation in the Bulgarian Roma (Gypsy) population: prevalence study and carrier screening in a high-risk community.
Topics: Bulgaria; Female; Genetic Carrier Screening; Genetic Testing; Genetics, Population; Humans; Infant, | 2004 |